Human Herpesvirus 6 Reactivation Associated With Intestinal Pseudo-Obstruction in a Renal Transplant Recipient

Exp Clin Transplant. 2022 Feb;20(2):209-212. doi: 10.6002/ect.2021.0315. Epub 2022 Jan 14.

Abstract

Human herpesvirus 6 infection is common after organ transplant. Generally, infection is asymptomatic or is associated with a mild illness. However, human herpesvirus 6 infection in these patients may as well be life threatening as a result of severe end-stage organ disease. Here, we have reported a case of a severe human herpesvirus 6 infection with cerebral, hepatic, and gastrointestinal involvement, which presented as intestinal pseudo-obstruction. The patient was a renal transplant recipient who was successfully treated with ganciclovir. We also reviewed the literature on human herpesvirus 6 diagnosis and the associated colitis and encephalitis with its infection in solid-organ transplant recipients.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use
  • Herpesvirus 6, Human*
  • Humans
  • Intestinal Pseudo-Obstruction* / diagnosis
  • Intestinal Pseudo-Obstruction* / drug therapy
  • Intestinal Pseudo-Obstruction* / etiology
  • Kidney Transplantation* / adverse effects
  • Roseolovirus Infections* / diagnosis
  • Roseolovirus Infections* / drug therapy
  • Transplant Recipients
  • Treatment Outcome

Substances

  • Antiviral Agents